Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients

Parasite Immunology

Volumn 22, Issue 2, 2000, Pages 73-79

  Cabrera, Maira ^a,b   Blackwell, Jenefer M ^b,c   Castes, Marianella ^a   Trujillo, Dinorah ^a   Convit, Jacinto ^a   Shaw, Marie Anne ^b,d  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

BCG; Cutaneous leishmaniasis; Immunotherapy

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 5; LEISHMANIA VACCINE; MEGLUMINE ANTIMONATE;

ADULT; ARTICLE; BLOOD LEVEL; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LEISHMANIA; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TH1 CELL;

ADOLESCENT; ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; BCG VACCINE; CELL DIVISION; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-5; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS; LYMPHOCYTE ACTIVATION; MALE; MEGLUMINE; MIDDLE AGED; MYCOBACTERIUM BOVIS; ORGANOMETALLIC COMPOUNDS; PROTOZOAN VACCINES; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TUBERCULIN;

EID: 0033964083     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2000.00278.x     Document Type: Article

References (40)

1. Alvar J., Canavate C., Gutierrez-Solar B. et al. (1997) Leismania and human immunodeficiency virus coinfection: the first 10 years. Clinical Microbiology Reviews 10, 298-319
2. Barral-Netto M., Barral A., Brownell C.E. et al. (1992) Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science 257, 545-548
3. Bogdan C. & Rollinghoff M. (1998) The immune response to Leishmania: mechanisms of parasite control and evasion. International Journal of for Parasitology 28, 121-134
4. Cáceres-Dittmar G., Tapia F.J., Sanchez M.A. et al. (1993) Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clinical Experimental Immunology 91, 500-505
5. Carvalho E.M., Johnson W.D., Barreto E. et al. (1985) Cell mediated immunity in American cutaneous and mucosal leishmaniasis. Journal of Immunology 135, 4144-4148
6. Castes M., Agnelli A., Verde O. & Rondon A.J. (1983) Characterization of the cellular immune response in American cutaneous leishmaniasis. Clinical Immunology and Immunopathology 27, 176-186
7. Castes M., Blackwell J.M., Trujillo D. et al. (1994) Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes: skin test reactivity, T cell proliferation and interferon-production. Vaccine 12, 1041-1051
8. Castes M., Cabrera M., Trujillo D. et al. (1996) Cytokine profile in human american cutaneous leishmaniasis. New dimensions in parasitology Acta Parasitologica Turcica Suppl.1), 45-57
9. Castes M., Cabrera M., Trujillo D. & Convit J. (1988) T-cell subpopulations, expression of interleukin-2 receptor and production of interleukin-2 and interferon-γ in human american cutaneous leishmaniasis. Journal of Clinical Microbiology 26, 1207-1213
10. Castes M., Moros Z., Martinez A. et al. (1989) Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after immunotherapy and chemotherapy. Parasite Immunology 11, 211-222
11. Castes M., Trujillo D., Rojas M.E. et al. (1993) Serum levels of tumour necrosis factor in patients with American cutaneous leishmaniasis. Biological Research 26, 233-238
12. Convit J. (1974) Leprosy and leishmaniasis. Similar clinical-immunological-pathological models. Ethiopian Medical Journal 12, 187-195
13. Convit J., Castellanos P.L., Rondon A. et al. (1987) Immunotherapy versus chemotherapy in localized cutaneous leishmaniasis. Lancet 21, 401-405
14. Convit J., Castellanos P.L., Ulrich M. et al. (1989) Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. Journal of Infectious Diseases 160, 104-115
15. Convit J., Pinardi M.E. & Rondon A. (1972) Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. Transactions of the Royal Society of Tropical Medicine and Hygiene 66, 603-610
16. Convit J., Ulrich M., Fernández C.T. et al. (1993) The clinical and immunological spectrum of American cutaneous leishmaniasis Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 444-448
17. Cooper A.M., Rosen H. & Blackwell J.M. (1988) Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle. Immunology 65, 511-514
18. Frommel D. & Lagrange P.H. (1989) BCG: a modifier of immune response to parasites. Parasitology Today 5, 188-190
19. Grogl M., Thomason T.N. & Franke E.D. (1992) Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. American Journal of Tropical Medicine and Hygiene 47, 117-126
20. Heinzel F.P., Sadick M.D., Holaday B.J. et al. (1989) Reciprocal expresison of interferon-γ or interleukin-4 during the resolution or progression of murine leishmaniasis. Evidence for the expansion of distinct helper T cell subsets. Journal of Experimental Medicine 169, 59-72
21. Jernigan J.A. & Pearson (1993) Chemotherapy of leishmaniasis, Chagas's disease and African trypanosomiasis. Current Opinion in Infectious Diseases 6, 794-802
22. Kemp M., Hey A.S., Kurtzhals J.A.L. et al. (1994) Dichotomy of the human T cell response to Leishmania antigens. I Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clinical and Experimental Immunology 96, 410-415
23. Marshall B.G., Chambers M.A., Wangoo A., Shaw R.J. & Young D.B. (1997) Production of tumor necrosis factor and nitric oxide by macrophages infected with live and dead mycobacteria and their suppression by an interleukin-10-secreting recombinant. Infection and Immunity 65, 1931-1935
24. Matsumoto H., Suzuki K., Tsuyuguchi K. et al. (1997) Interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: cytokine regulation and effect of NK cells. Infection and Immunity 65, 4405-4410
25. Melby P.C., Andrade-Narvaez F., Darnell B.J. et al. (1994) Increased expression of proinflamatory cytokines in chronic lesions of human cutaneous leishmaniasis Infection and Immunity 62, 837-842
26. Melby P.C., Andrare-Narvaez F., Darnell B.J. & Valencia-Pacheco G. (1996) In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis. FEMS Immunology and Medial Microbiology 15, 101-107
27. Melby P.C., Neva F.A. & Sacks D. (1989) Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting. Journal of Clinical Investigation 83, 1868-1875
28. Mossman T.R. & Sad S. (1996) The expanding universe of T cell subsets: Th1, Th2 and more. Immunology Today 17, 138-146
29. Muller I., Kropf P., Etges R.J. & Louis J.A. (1993) Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells. Infection and Immunity 61, 3730-3738
30. Murray H.W. (1990) Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. In vitro, in animal models, and in humans. Diagnostic Microbiology and Infectious Disease 13, 411-421
31. Pirmez C., Cooper C., Paes-Oliveira M. et al. (1990) Immunogenic responsiveness in American cutaneous leishmaniasis lesions. Journal of Immunology 145, 3100-3104
32. Pirmez C., Yamamura M., Uyemura K. et al. (1993) Cytokine patterns in the pathogenesis of human leishmaniasis. Journal of Clinical Investigation 91, 1390-1395
33. Rada E., Trujillo D., Castellanos P.L. & Convit J. (1987) Gamma interferon production induced by antigens in patients with leprosy and American cutaneous leishmaniasis. American Journal of Tropical Medicine and Hygiene 37, 520-524
34. Rolink A.G., Melchers F. & Palacios R. (1989) Monoclonal antibody reactive with the mouse interleukin-5 receptor. Journal of Experimental Medicine 169, 1693-1701
35. Russo D.M., Chakrabarti P. & Burns J.M. Jr (1998) Naive human T cells develop into Th1 or Th0 effectors and exhibit cytotoxicity early after stimulation with Leishmania-infected macrophages. The Journal of Infectious Diseases 177, 1345-1351
36. Salgame P., Abrams J.S., Clayberg C. et al. (1991) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254, 279-282
37. Saravia N., Valderrama L., Labrada M. et al. (1989) The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. Journal of Infectious Diseases 159, 725-735
38. Scott P., Natovitz. P., Coffman R.L., Pearce E. & Sher A. (1988) Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. Journal of Experimental Medicine 168, 675-679
39. Silveira F.T., Blackwell J.M., Ishikawa E.A. et al. (1998) T cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia. Parasite Immunology 20, 19-26
40. Surcel H.M., Troye-Blomberg M., Paulie S. et al. (1994) Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81, 171-176